human
metapneumoviru
hmpv
associ
acut
infect
respiratori
tract
increas
sever
children
infant
elderli
immunocompromis
patient
hmpv
identifi
netherland
sort
pneumovirida
famili
preval
children
infant
requir
hospit
worldwid
reach
moreov
serolog
studi
show
children
seroposit
age
five
symptom
associ
infect
usual
mild
eg
cough
subfebril
temperatur
sever
diseas
also
occur
eg
bronchiti
pneumonia
hmpv
f
protein
util
heparan
sulfat
hs
neg
charg
glycosaminoglycan
gag
present
cellular
membran
attach
factor
previou
studi
shown
natur
polysaccharid
contain
sulfon
group
effici
inhibit
infect
caus
virus
employ
hs
cell
entri
propos
carrageenan
inhibit
attach
hmpv
hs
interact
f
protein
howev
worth
mention
replic
hs
independ
virus
also
hamper
presenc
polym
current
countri
main
compon
nasal
spray
use
prevent
respiratori
viral
infect
previou
report
show
nsulfon
deriv
poli
allylamin
hydrochlorid
nspah
effect
inhibit
influenza
viru
vitro
ex
vivo
inhibit
virion
releas
infect
cell
surprisingli
show
new
compound
share
mechan
action
differ
previous
propos
although
antivir
activ
nspah
compar
one
observ
carrageenan
physicochem
properti
nspah
seem
superior
aim
studi
examin
antihmpv
activ
nspah
seri
vitro
experi
conduct
two
nspah
deriv
select
studi
molecular
mass
mw
kda
degre
substitut
sulfon
group
ds
mw
kda
ds
potent
inhibitor
hmpv
replic
preliminari
studi
refer
two
sulfon
polysaccharid
wellestablish
antivir
properti
use
synthes
analyz
purifi
dialysi
describ
purif
process
carri
deioniz
water
week
molecular
mass
cutoff
kda
afterward
water
remov
freez
dri
give
product
paleyellow
crystal
iota
carrageenan
lambda
carrageenan
obtain
sigmaaldrich
poland
rhesu
monkey
kidney
epitheli
cell
atcc
maintain
minim
essenti
medium
mem
contain
part
earl
mem
two
part
hank
mem
thermo
scientif
poland
supplement
heatinactiv
fetal
bovin
serum
fb
paa
laboratori
austria
penicillin
uml
streptomycin
sigmaaldrich
poland
cell
propag
flask
tpp
switzerland
atmospher
contain
hmpv
viru
stock
clinic
isol
clade
kindli
provid
dr
oliv
schildgen
institut
patholog
wittenherdeck
univers
hmpv
viru
stock
strain
acquir
european
viru
archiv
virus
propag
describ
human
coronaviru
stock
prepar
describ
assay
carri
use
fulli
confluent
cell
per
well
cultur
h
plate
tpp
switzerland
cell
infect
viru
tissu
cultur
infecti
dose
per
ml
moi
dmem
dulbecco
modifi
eagl
medium
thermo
scientif
poland
depriv
fb
supplement
penicillin
uml
streptomycin
gentamicin
amphotericin
trypsin
sigmaaldrich
poland
viru
titer
assess
describ
reed
muench
cell
viabil
evalu
use
xtt
cell
viabil
assay
kit
biolog
industri
usa
accord
manufactur
instruct
cell
incub
test
polym
day
atmospher
contain
incub
medium
discard
cell
rins
phosphatebuff
salin
pb
fresh
medium
ad
well
next
activ
xtt
solut
ad
sampl
incub
h
absorb
nm
measur
use
spectra
max
spectrophotomet
molecular
devic
usa
viru
yield
determin
revers
transcript
rt
quantit
realtim
pcr
qpcr
ensur
polym
affect
isol
andor
amplif
templat
supernat
dilut
time
total
rna
isol
viral
dnarna
kit
biotechnolog
poland
accord
manufactur
instruct
revers
transcript
reaction
carri
highcapac
cdna
revers
transcript
kit
thermo
scientif
poland
accord
manufactur
instruct
qpcr
perform
rt
hspcr
mix
probe
biotechnolog
poland
describ
hmpv
primer
nm
gct
gtc
agc
ttc
agt
caa
ttc
aa
gtt
atc
cct
gca
ttg
tct
gaa
aac
probe
nm
aca
aca
ttt
agg
aat
ctt
ctmgb
primer
nm
cct
cgt
tgg
aag
cgt
tgg
aaa
acc
ttt
ggc
probe
nm
tta
ttc
agt
gct
ttg
gtc
ctc
gtg
number
viru
copi
determin
use
seri
dilut
dna
standard
contain
known
number
templat
copi
reaction
carri
follow
min
min
follow
cycl
min
viru
standard
curv
prepar
separ
lower
limit
detect
viral
rna
copi
per
millilit
studi
antivir
properti
compound
cell
infect
hmpv
inocul
mock
sampl
presenc
absenc
polym
h
infect
unabsorb
hmpv
virion
remov
rins
cell
thrice
pb
subsequ
media
supplement
inhibitor
ad
cultur
incub
day
incub
cultur
supernat
analyz
titrat
rtqpcr
describ
assay
show
influenc
test
compound
viral
particl
polym
final
concentr
mix
viru
stock
incub
h
room
temperatur
mix
rpm
hmpv
stock
incub
absenc
polym
treat
control
incub
sampl
dilut
time
ensur
polym
concentr
lower
limit
effect
rang
sampl
titrat
describ
reed
muench
assay
show
effect
polym
cell
confluent
cultur
cell
inocul
polym
solut
per
well
sampl
incub
h
media
remov
viru
mock
solut
moi
ad
well
h
incub
media
discard
cell
rins
thrice
pb
remov
residu
viru
particl
fresh
medium
ad
well
plate
incub
day
assay
allow
examin
effect
compound
virusreceptor
interact
confluent
cultur
cell
precool
overlaid
media
supplement
test
polym
viru
moi
mock
control
sampl
incub
h
allow
viru
attach
block
viru
intern
incub
cell
rins
thrice
icecold
pb
remov
residu
viru
particl
fresh
medium
ad
cell
incub
day
assay
allow
evalu
viru
entri
suscept
cell
precool
confluent
cell
infect
hmpv
moi
treat
mock
plate
incub
h
allow
viru
attach
intern
supernat
discard
cell
wash
thrice
icecold
pb
remov
unbound
viru
particl
next
media
supplement
polym
ad
cell
incub
h
allow
viru
intern
final
supernat
discard
cell
wash
acid
buffer
ph
glycin
sodium
chlorid
inactiv
particl
enter
cell
cultur
incub
day
medium
depriv
polym
assay
eevalu
viru
replic
product
infecti
progeni
confluent
cell
incub
hmpv
moi
infect
carri
h
subsequ
medium
discard
cultur
rins
thrice
pb
cell
overlaid
media
supplement
polym
control
sampl
incub
day
test
supernat
cell
lysat
analyz
lysat
prepar
fast
cycl
freez
thaw
buffer
biotechnolog
poland
confoc
microscopi
analysi
replic
inhibit
assay
perform
cell
seed
coverslip
plate
tpp
switzerland
subsequ
cell
wash
pb
fix
paraformaldehyd
permeabil
triton
incub
h
bovin
serum
albumin
bsa
contain
tween
sigmaaldrich
poland
subsequ
cell
incub
h
mous
antihmpv
fprotein
antibodi
ingenasa
spain
cell
incub
h
alexa
fluor
goat
antimous
antibodi
molecular
probe
usa
nuclear
dna
stain
dapi
sigmaaldrich
poland
fluoresc
imag
acquir
nikon
eclips
tie
confoc
microscop
imag
softwar
nikon
instrument
europ
bv
amsterdam
netherland
experi
conduct
least
triplic
result
express
mean
standard
deviat
sd
inhibitori
concentr
valu
calcul
use
graph
pad
prism
function
determin
signific
result
obtain
student
ttest
use
p
valu
consid
signific
viru
yield
viru
titer
present
normal
data
ie
log
reduct
valu
lrv
easier
comparison
inhibitori
effect
assay
lrv
calcul
accord
follow
formula
lrv
log
ci
number
viral
rna
copi
per
millilit
sampl
treat
inhibitor
number
viral
rna
copi
per
millilit
control
sampl
untreat
cell
raw
research
data
number
copi
per
millilit
valu
present
support
inform
file
cell
incub
day
presenc
absenc
evalu
compound
cell
viabil
assess
use
xtt
assay
cytotox
observ
control
lower
concentr
viabil
cell
affect
fig
obtain
result
consist
previous
publish
data
initi
experi
polym
test
abil
hamper
hmpv
replic
cell
cell
overlaid
media
supplement
polym
control
sampl
hmpv
mock
sampl
polym
present
whole
experi
compound
suppress
viru
replic
rtqpcr
least
log
unit
valu
respect
fig
fig
test
infect
progeni
viru
also
diminish
cell
cultur
supernat
titrat
visibl
fig
exhibit
best
antivir
properti
confoc
imag
confirm
observ
presenc
polym
number
infect
cell
lower
compar
control
fig
ensur
broad
specif
nspah
toward
differ
hmpv
strain
studi
perform
also
use
differ
hmpv
strain
clade
similar
antivir
effect
observ
fig
fig
next
step
aim
elucid
mechan
action
describ
polym
inhibit
earli
step
viru
infect
note
carrageenan
nspah
first
four
function
assay
fig
observ
strong
inhibit
progeni
viru
product
assay
wherein
inhibitor
ad
h
inocul
test
compound
inhibit
hmpv
progeni
viru
product
illustr
decreas
viru
yield
titer
p
rtqpcr
analysi
indic
inhibit
profound
ca
log
unit
fig
black
bar
fig
titrat
supernat
reveal
compound
inhibit
product
hmpv
infecti
virion
ca
log
unit
fig
grey
bar
fig
obtain
result
suggest
test
polym
hamper
late
stage
viru
replic
cycl
viru
enter
cell
investig
mechan
supernat
infect
cultur
discard
cell
lyse
three
freez
thaw
cycl
titrat
lysi
buffer
rna
isol
surprisingli
rtqpcr
analysi
reveal
minor
inhibit
p
viral
rna
replic
carrageenan
inhibitori
activ
nspah
fig
black
bar
fig
consist
previou
result
influenza
viru
case
titrat
observ
slight
signific
increas
infect
sampl
case
also
increas
infect
cell
lysat
howev
increas
statist
nonsignific
fig
grey
bar
fig
indic
hmpv
virion
correctli
progress
bud
stage
presenc
polym
remain
cellassoci
altogeth
obtain
data
indic
nspah
affect
viru
replic
per
se
lock
cell
limit
spread
neighbor
cell
previou
report
suggest
inhibit
earli
stage
viral
replic
carrageenan
abl
replic
result
howev
possibl
mechan
action
may
depend
origin
natur
polym
studi
whether
observ
antivir
effect
virusspecif
cell
line
infect
unrel
viru
ie
human
coronaviru
viru
effici
replic
cell
releas
cell
differ
mechan
contrast
hmpv
influenza
virus
bud
cell
surfac
bud
golgi
apparatu
matur
infecti
viral
particl
transport
via
exocytosi
cell
surfac
none
test
polym
inhibit
fig
fig
observ
suggest
polym
block
viru
releas
cell
surfac
eg
modif
membran
plastic
anchor
progeni
virion
cell
one
may
also
consid
differ
nspah
activ
hmpv
result
differ
requir
hspg
presenc
would
explain
strong
inhibitori
effect
nspah
influenza
viru
moreov
also
shown
employ
hspg
entri
cell
sum
demonstr
dosedepend
inhibit
hmpv
replic
sulfon
poli
allylamin
base
polym
among
test
polym
show
strongest
antivir
properti
hmpv
studi
mechan
antihmpv
properti
test
polym
impli
decreas
sampl
infect
due
block
viru
releas
cellular
membran
develop
synthet
polym
toxic
offer
similar
antivir
properti
carrageenan
show
better
physicochem
properti
previou
work
report
nspah
hamper
influenza
viru
replic
vitro
vivo
believ
may
consid
broadspectrum
drug
candid
competit
market
compound
